This trial will assess whether or not Stellate Ganglion Block (SGB), a treatment established to relieve pain, can also help reduce the symptoms of Posttraumatic Stress Disorder (PTSD).
2 Primary · 1 Secondary · Reporting Duration: 8 weeks after SGB, Sham, or WLC enrollment
Active Control
Non-Treatment Group
360 Total Participants · 3 Treatment Groups
Primary Treatment: SGB · Has Placebo Group · N/A
Age 18 - 55 · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Wisconsin | 100.0% |
18 - 65 | 100.0% |
William S. Middleton Memorial Veterans Hospital, Madison, WI | 100.0% |
Met criteria | 100.0% |